株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

タイの医薬品・医療産業(四半期更新レポート)

Thailand Pharmaceuticals and Healthcare Report Q3 2017

発行 BMI Research 商品コード 243374
出版日 ページ情報 英文 97 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.17円で換算しております。
Back to Top
タイの医薬品・医療産業(四半期更新レポート) Thailand Pharmaceuticals and Healthcare Report Q3 2017
出版日: 2017年07月12日 ページ情報: 英文 97 Pages
担当者のコメント
このシリーズは、他にも調査対象国がございます。詳細はお問合せください。
概要

当レポートでは、タイにおける製薬・医療産業の構造や最新動向について分析し、今後10年間の産業規模の動きを推計すると共に、業界の抱える課題(リスク)や将来的な収益機会(リワード)に関する評価、政府の政策・規制、マクロ経済環境、主要企業のプロファイルといった情報を盛り込んでお届けします。

BMIの見解

SWOT分析

産業予測

  • 医薬品市場の予測
  • 医療市場の予測
  • 処方薬市場の予測
  • 特許薬市場の予測
  • ジェネリック医薬品市場の予測
  • 一般用(OTC)医薬品市場の予測
  • 医薬品の対外貿易状況

産業のリスク/リワード・インデックス

  • アジア太平洋地域:リスク/リワード・インデックス
  • タイ:リスク/リワード・インデックス
    • リワード
    • リスク

規制概要

  • 知的所有権(IP)の問題
  • 価格設定
  • 医療費償還

市場概況

  • 医療部門
  • 研究開発(R&D)部門
  • 治験
  • 疫学

競争環境

  • 研究開発指向型産業
  • ジェネリック医薬品メーカー
  • 医薬品の卸売業
  • 医薬品の小売業

企業プロファイル

  • Berlin Pharmaceutical Industry
  • Biolab
  • GlaxoSmithKline
  • Government Pharmaceutical Organisation
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi

人口構造の予測

用語集

分析手法

  • 医薬品支出額の予測モデル
  • 医療費の予測モデル
  • 分析手法に関する注記
  • リスク/リワード・インデックスの手法
  • インデックスの概要
  • 指標のウェイト付け

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 1748-2240

BMI View: While Thailand's growing population and universal health coverage offer many positives, the business environment for multinationals will remain below par. In addition to unresolved intellectual property issues, the mounting downward pressure on pharmaceutical prices through calls for declaration of production costs, and the worsening demographic profile, the attractiveness of the country's pharmaceutical and healthcare markets will diminish, unless the issues are addressed.

Headline Expenditure Projections:

  • Pharmaceuticals: THB161.0bn (USD4.6bn) in 2016 to THB169.6bn (USD4.9bn) in 2017; +5.3% in local currency terms and +7.7% in US dollar terms.
  • Healthcare: THB892.3bn (USD25.3bn) in 2016 to THB946.2bn (USD27.4bn) in 2017; +5.9% in local currency terms and 6.6% in US dollar terms.

Latest Updates:

  • Thailand's business environment will remain decidedly difficult for multinational pharmaceutical firms, as the country maintained its position on the 'Priority Watch List' in the Pharmaceutical Research and Manufacturers of America (PhRMA)'s Special 301 submission for 2017, with many of the shortcomings previously raised still unaddressed.
  • In April 2017, Bangkok Post reported that, under a new proposal that is expected to come into force in mid-year, informal workers (such as taxi drivers and street vendors) who are members by the Social Security Fund (SSF) will receive an increase of up to a half (to THB300) in relation to daily hospital compensation.

Table of Contents

BMI Industry View

  • Table: Headline Pharmaceuticals & Healthcare Forecasts (Thailand 2015-2021)

SWOT

Industry Forecast

  • Pharmaceutical Market Forecast
    • Table: Pharmaceutical Sales, Historical Data And Forecasts (Thailand 2013-2021)
  • Healthcare Market Forecast
    • Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2013-2021)
    • Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2013-2021)
    • Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2013-2021)
  • Prescription Drug Market Forecast
    • Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Thailand 2013-2021)
  • Patented Drug Market Forecast
    • Table: Patented Drug Market Indicators, Historical Data And Forecasts (Thailand 2013-2021)
  • Generic Drug Market Forecast
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Thailand 2013-2021)
  • OTC Drug Market Forecast
    • Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Thailand 2013-2021)
  • Pharmaceutical Trade Forecast
    • Table: Pharmaceutical Trade Data And Forecasts (Thailand 2015-2021)
    • Table: Pharmaceutical Trade Data And Forecasts local currency (Thailand 2015-2021)

Industry Risk/Reward Index

  • Asia Pacific Risk/Reward Index

Regulatory Review

  • Intellectual Property Issues
    • Table: Special 301 Submission 2017: Issues Raised For Thailand
  • Pricing Regime
    • Table: Price Build-Up Of Medicines In Thailand
  • Reimbursement Regime

Market Overview

  • Healthcare Sector
    • Table: Major Health Insurance Programmes In Thailand
    • Table: Healthcare Resources (Thailand 2011-2016)
    • Table: Healthcare Personnel (Thailand 2011-2016)
    • Table: Healthcare Activity (Thailand 2011-2016)
  • Research & Development
  • Clinical Trials
  • Epidemiology
    • Table: Estimated Number Of New Cases Of Cancer In Thailand

Competitive Landscape

  • Research-Based Industry
    • Table: PReMA Members
    • Table: Multinational Market Activity
  • Generic Drugmakers
    • Table: Pharmaceutical Manufacturers Of Modern Drugs, 2007-2012
  • Pharmaceutical Distribution
  • Pharmaceutical Retail Sector

Company Profile

  • Berlin Pharmaceutical Industry
  • Biolab
  • GlaxoSmithKline
  • Government Pharmaceutical Organisation
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi

Demographic Forecast

  • Demographic Outlook
    • Table: Population Headline Indicators (Thailand 1990-2025)
    • Table: Key Population Ratios (Thailand 1990-2025)
    • Table: Urban/Rural Population & Life Expectancy (Thailand 1990-2025)
    • Table: Population By Age Group (Thailand 1990-2025)
    • Table: Population By Age Group % (Thailand 1990-2025)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
    • Table: Indicators - Rationale And Sources
Back to Top